D A Carranza-León1, A Oeser1, A Marton2, P Wang3, J C Gore3, J Titze2, C M Stein1,4, C P Chung1,5, M J Ormseth1,5. 1. Department of Medicine, Vanderbilt University Medical Center, USA. 2. Department of Medicine, Duke-NUS Medical School, Singapore. 3. Department of Radiology, Vanderbilt University Medical Center, USA. 4. Department of Pharmacology, Vanderbilt University Medical Center, USA. 5. Tennessee Valley Healthcare System, US Department of Veterans Affairs, USA.
Abstract
OBJECTIVES: Sodium (Na+) is stored in the skin and muscle and plays an important role in immune regulation. In animal models, increased tissue Na+ is associated with activation of the immune system, and high salt intake exacerbates autoimmune disease and worsens hypertension. However, there is no information about tissue Na+ and human autoimmune disease. We hypothesized that muscle and skin Na+ content is (a) higher in patients with systemic lupus erythematosus (SLE) than in control subjects, and (b) associated with blood pressure, disease activity, and inflammation markers (interleukin (IL)-6, IL-10 and IL-17 A) in SLE. METHODS: Lower-leg skin and muscle Na+ content was measured in 23 patients with SLE and in 28 control subjects using 23Na+ magnetic resonance imaging. Demographic and clinical information was collected from interviews and chart review, and blood pressure was measured. Disease activity was assessed using the SLE Disease Activity Index (SLEDAI). Plasma inflammation markers were measured by multiplex immunoassay. RESULTS: Muscle Na+ content was higher in patients with SLE (18.8 (16.7-18.3) mmol/L) than in control subjects (15.8 (14.7-18.3) mmol/L; p < 0.001). Skin Na+ content was also higher in SLE patients than in controls, but this difference was not statistically significant. Among patients with SLE, muscle Na+ was associated with SLEDAI and higher concentrations of IL-10 after adjusting for age, race, and sex. Skin Na+ was significantly associated with systolic blood pressure, but this was attenuated after covariate adjustment. CONCLUSION: Patients with SLE had higher muscle Na+ content than control subjects. In patients with SLE, higher muscle Na+ content was associated with higher disease activity and IL-10 concentrations.
OBJECTIVES:Sodium (Na+) is stored in the skin and muscle and plays an important role in immune regulation. In animal models, increased tissue Na+ is associated with activation of the immune system, and high salt intake exacerbates autoimmune disease and worsens hypertension. However, there is no information about tissue Na+ and humanautoimmune disease. We hypothesized that muscle and skin Na+ content is (a) higher in patients with systemic lupus erythematosus (SLE) than in control subjects, and (b) associated with blood pressure, disease activity, and inflammation markers (interleukin (IL)-6, IL-10 and IL-17 A) in SLE. METHODS: Lower-leg skin and muscle Na+ content was measured in 23 patients with SLE and in 28 control subjects using 23Na+ magnetic resonance imaging. Demographic and clinical information was collected from interviews and chart review, and blood pressure was measured. Disease activity was assessed using the SLE Disease Activity Index (SLEDAI). Plasma inflammation markers were measured by multiplex immunoassay. RESULTS: Muscle Na+ content was higher in patients with SLE (18.8 (16.7-18.3) mmol/L) than in control subjects (15.8 (14.7-18.3) mmol/L; p < 0.001). Skin Na+ content was also higher in SLEpatients than in controls, but this difference was not statistically significant. Among patients with SLE, muscle Na+ was associated with SLEDAI and higher concentrations of IL-10 after adjusting for age, race, and sex. Skin Na+ was significantly associated with systolic blood pressure, but this was attenuated after covariate adjustment. CONCLUSION:Patients with SLE had higher muscle Na+ content than control subjects. In patients with SLE, higher muscle Na+ content was associated with higher disease activity and IL-10 concentrations.
Entities:
Keywords:
Lupus; inflammation; magnetic resonance image; sodium
Authors: Christoph Kopp; Peter Linz; Matthias Hammon; Christof Schöfl; Martin Grauer; Kai-Uwe Eckardt; Alexander Cavallaro; Michael Uder; Friedrich C Luft; Jens Titze Journal: Kidney Int Date: 2012-12 Impact factor: 10.612
Authors: Kelli P A MacDonald; Vanessa Rowe; Helen M Bofinger; Ranjeny Thomas; Tedjo Sasmono; David A Hume; Geoffrey R Hill Journal: J Immunol Date: 2005-08-01 Impact factor: 5.422
Authors: L Pacheco-Lugo; J Sáenz-García; E Navarro Quiroz; H González Torres; L Fang; Y Díaz-Olmos; G Garavito de Egea; E Egea Bermejo; G Aroca Martínez Journal: Lupus Date: 2018-11-19 Impact factor: 2.911
Authors: Yu Asanuma; Cecilia P Chung; Annette Oeser; Ayumi Shintani; Eran Stanley; Paolo Raggi; C Michael Stein Journal: J Rheumatol Date: 2006-02-01 Impact factor: 4.666
Authors: Natalia R Barbaro; Jason D Foss; Dmytro O Kryshtal; Nikita Tsyba; Shivani Kumaresan; Liang Xiao; Raymond L Mernaugh; Hana A Itani; Roxana Loperena; Wei Chen; Sergey Dikalov; Jens M Titze; Bjorn C Knollmann; David G Harrison; Annet Kirabo Journal: Cell Rep Date: 2017-10-24 Impact factor: 9.423
Authors: Konstantin Huhn; Peter Linz; Franziska Pemsel; Bernhard Michalke; Stefan Seyferth; Christoph Kopp; Mohammad Anwar Chaudri; Veit Rothhammer; Arnd Dörfler; Michael Uder; Armin M Nagel; Dominik N Müller; Anne Waschbisch; De-Hyung Lee; Tobias Bäuerle; Ralf A Linker; Stefanie Haase Journal: Proc Natl Acad Sci U S A Date: 2021-07-13 Impact factor: 11.205
Authors: Thomas Dörner; Yoshiya Tanaka; Ernst R Dow; Alisa E Koch; Maria Silk; Jorge A Ross Terres; Jonathan T Sims; Zhe Sun; Inmaculada de la Torre; Michelle Petri Journal: Ann Rheum Dis Date: 2022-05-24 Impact factor: 27.973